Page last updated: 2024-12-05

methyl n-butyl ketone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Methyl n-Butyl Ketone: An industrial solvent which causes nervous system degeneration. MBK is an acronym often used to refer to it. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

hexanone : A ketone that is a hexane carrying an oxo substituent at unspecified position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11583
CHEMBL ID195861
CHEBI ID89206
SCHEMBL ID43282
MeSH IDM0013615

Synonyms (58)

Synonym
4-01-00-03298 (beilstein handbook reference)
6qdy60nh6n ,
ccris 8810
unii-6qdy60nh6n
n-butyl methyl ketone
591-78-6
2-hexanone methyl n-butyl ketone
einecs 209-731-1
butyl methyl ketone
methyl butyl ketone
propylacetone
hexanone-2
methyl n-butyl ketone
ketone, butyl methyl
2-oxohexane
brn 1737676
hsdb 543
2-hexanone
hexan-2-one
inchi=1/c6h12o/c1-3-4-5-6(2)7/h3-5h2,1-2h
hexanone
chebi:89206 ,
CHEMBL195861
H0114
AKOS000118992
A801945
A832195
LMFA12000048
BBL011434
30637-87-7
2-HEXANONE_GURUDEEBANSATYAVANI
mnbk
STL146542
FT-0612492
2-hexanone [hsdb]
methyl butyl ketone [mi]
methyl-n-butyl ketone
methylbutylketone [usp-rs]
SCHEMBL43282
hexane-2-one
methyl-4-pentanone
2 -hexanone
2-hexanal
methylbutyl ketone
STR04219
n-c4h9coch3
DTXSID0022068
J-509559
F0001-1552
mfcd00009482
2-hexanone, reagent grade, 98%
2-hexanone, analytical standard
2-hexanone, purum, >=96.0% (gc)
Q209404
Q63399049
?2-hexanone
EN300-19141
PD124154

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" the Leydig cell, is a potential site for the primary toxic effects of these agents in the rat testis."( Gonadotoxic effects of 2-hexanone and 1,2-dibromo-3-chloropropane on the enzymatic activity of rat testicular 17 alpha-hydroxylase/C17,20-lyase.
Ganjam, VK; Kelce, WR; Raisbeck, MF, 1990
)
0.28
" The 14 weeks of exposure had no adverse effect on the clinical health or growth of rats or mice."( A 14-week vapor inhalation toxicity study of methyl isobutyl ketone.
Dodd, DE; Fowler, EH; Kary, CD; Moran, EJ; O'Donoghue, J; Phillips, RD, 1987
)
0.27
" In renal cortical slices, deuterated-CHCl3 was less toxic than CHCl3."( Role of intrarenal biotransformation in chloroform-induced nephrotoxicity in rats.
Hewitt, WR; Hook, JB; Smith, JH, 1985
)
0.27
" This dose approximates the single dose LD50 (2."( Further studies on ketone neurotoxicity and interactions.
DiVincenzo, GD; Katz, GV; Krasavage, WJ; O'Donoghue, JL, 1984
)
0.27
" MIBK was not toxic via the oral or dermal route of exposure in acute, short-term, or subchronic animal studies, except that nephrotoxicity was observed in rats dosed with 1 g/kg in a short-term study."( Safety assessment of MIBK (methyl isobutyl ketone).
Johnson, W, 2004
)
0.32
" There was a dose-related increase in adult animals with no or a decreased response to a sound stimulus at 1000 and 2000 ppm; however, no adverse clinical signs occurred 1 h after exposure, suggesting this was a transient sedative effect."( Inhalation two-generation reproductive toxicity study of methyl isobutyl ketone in rats.
Gingell, R; Harris, SB; Nemec, MD; Pavkov, KL; Pitt, JA; Rauckman, EJ; Topping, DC,
)
0.13
" In order to evaluate the potential of MIBK to induce toxic and carcinogenic effects following chronic exposure, groups of 50 male and 50 female F344/N rats and B6C3F1 mice were exposed to MIBK at concentrations of 0, 450, 900, or 1800ppm by inhalation, 6h/day, 5 days per week for 2 years."( Toxicity and carcinogenicity of methyl isobutyl ketone in F344N rats and B6C3F1 mice following 2-year inhalation exposure.
Bucher, JR; Chhabra, RS; Herbert, RA; Kissling, GE; Roycroft, JH; Stout, MD; Suarez, F, 2008
)
0.35

Compound-Compound Interactions

ExcerptReferenceRelevance
"This investigation was designed to study the neurotoxicity produced in hens by the aliphatic hexacarbons n-hexane, methyl n-butyl ketone (MnBK), 2,5-hexanediol (2,5-HDOH), and 2,5-hexanedione (2,5-HD) following daily dermal application of each chemical alone and in combination with O-ethyl O-4-nitrophenyl phenylphosphonothioate (EPN)."( Pattern of neurotoxicity of n-hexane, methyl n-butyl ketone, 2,5-hexanediol, and 2,5-hexanedione alone and in combination with O-ethyl O-4-nitrophenyl phenylphosphonothioate in hens.
Abou-Donia, MB; Campbell, GM; Makkawy, HM, 1985
)
0.75

Dosage Studied

ExcerptRelevanceReference
" Dose-response investigations of the effects of MBK (oral) and MAK (ip) showed for both solvents a reduction in the response rate of rats trained on a multiple schedule of reinforcement."( Neurobehavioral effects of methyl N-butyl ketone and methyl N-amyl ketone in rats and monkeys: a summary of NIOSH investigations.
Anger, WK; Johnson, BL; Lewis, TR; Lynch, DW; Setzer, JV,
)
0.43
" Moreover, the minimally effective dosage needed to potentiate CHCl3-induced hepatotoxicity was approximately 5 mmol/kg for the three compounds."( Potentiation of chloroform-induced hepatotoxicity by methyl isobutyl ketone and two metabolites.
du Souich, P; Greselin, E; Kobusch, AB; Plaa, GL; Vézina, M, 1990
)
0.28
" Following the pretreatment at various time intervals ranging from 10 to 96 hr, groups of animals received a challenging dosage of CHCl3 (0."( Modifications in rat hepatobiliary function following treatment with acetone, 2-butanone, 2-hexanone, mirex, or chlordecone and subsequently exposed to chloroform.
Ayotte, P; Hewitt, LA; Plaa, GL, 1986
)
0.27
" The importance of the CCl4 dosage in these combinations, however, has not been explored."( Potentiation of CCl4-induced liver injury by ketonic and ketogenic compounds: role of the CCl4 dose.
Brodeur, J; Pilon, D; Plaa, GL, 1988
)
0.27
" Dose-response relationships for A, MEK, and MiBK potentiation of CCl4-induced hepatotoxicity and CHCl3-induced nephrotoxicity were compared."( Ketone potentiation of haloalkane-induced hepato- and nephrotoxicity. I. Dose-response relationships.
Plaa, GL; Raymond, P, 1995
)
0.29
" MIBK was not toxic via the oral or dermal route of exposure in acute, short-term, or subchronic animal studies, except that nephrotoxicity was observed in rats dosed with 1 g/kg in a short-term study."( Safety assessment of MIBK (methyl isobutyl ketone).
Johnson, W, 2004
)
0.32
" The results indicated that the continuous dosing (0."( Potential impact of methyl isobutyl ketone (MIBK) on phenols degradation in an UASB reactor and its degradation properties.
Hu, Z; Sierra, JM; Wang, W; Yang, K; Yuan, S; Zhang, X, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
ketoneA compound in which a carbonyl group is bonded to two carbon atoms: R2C=O (neither R may be H).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID237685Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (196)

TimeframeStudies, This Drug (%)All Drugs %
pre-199086 (43.88)18.7374
1990's36 (18.37)18.2507
2000's30 (15.31)29.6817
2010's32 (16.33)24.3611
2020's12 (6.12)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.77

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.77 (24.57)
Research Supply Index5.39 (2.92)
Research Growth Index4.49 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.77)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (1.39%)5.53%
Reviews16 (7.41%)6.00%
Case Studies4 (1.85%)4.05%
Observational0 (0.00%)0.25%
Other193 (89.35%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]